Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07485634
Eligibility Criteria:
Inclusion Criteria:
* Aged 65-74 years with impaired G8 questionnaire score, or aged 75 years or older.
* Diagnosis of lung cancer, colorectal cancer, breast cancer, gastric cancer, or uterine cancer with histological confirmation or radiological diagnosis.
* Scheduled to receive a new systemic anti-cancer treatment that includes chemotherapy. Any line of cytotoxic chemotherapy is allowed, including regimens combined with targeted therapy or immunotherapy, provided the planned regimen is expected to last at least 3 months.
* ECOG Performance Status 0-2.
* Able to communicate in English or Chinese.
* Able to provide valid informed consent.
Exclusion Criteria:
* Planned treatment with radiotherapy alone.
* Planned systemic treatment given concurrently with radiotherapy.
* Planned treatment with hormonal therapy alone (e.g., tamoxifen, aromatase inhibitors, LHRH agonists).
* Planned surgery within the next 3 months.
* Life expectancy less than 3 months.
* Dementia or otherwise mentally unfit to provide informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT07485634
Study Brief:
Protocol Section:
NCT07485634